Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer — Massimo Roncalli (2015) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Shared by
Alberto Mantovani
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Article
2015
en
Authors
+21 more
MR
Massimo Roncalli
PC
Piergiuseppe Colombo
LL
Luigi Laghi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Editorial Material
2015
PTX3 acts as an extrinsic oncosuppressor
Eduardo Bonavita
,
Alberto Mantovani
,
Cecília Garlanda
Article
2017
Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer
Marcello Rubino
,
Paolo Kunderfranco
,
Gianluca Basso
,
Carolina M. Greco
,
Fabio Pasqualini
,
Simone Serio
,
Massimo Roncalli
,
Luigi Laghi
,
Alberto Mantovani
,
Roberto Papait
,
Cecília Garlanda
Article
2017
Role of complement in cancer-related inflammation
Sabrina Di Marco
,
Elena Magrini
,
Kévin Berthenet
,
Maria Luisa Barbagallo
,
Nadia Polentarutti
,
Andrea Ponzetta
,
Alberto Mantovani
,
Cecília Garlanda
Article
2017
Role of complement in cancer-related inflammation
Elena Magrini
,
Sabrina Di Marco
,
Kévin Berthenet
,
Maria Luisa Barbagallo
,
Nadia Polentarutti
,
Andrea Ponzetta
,
Alberto Mantovani
,
Cecília Garlanda
Article
2017
Complement in cancer: untangling an intricate relationship
Edimara S. Reis
,
Dimitrios C. Mastellos
,
Daniel Ricklin
,
Alberto Mantovani
,
John D. Lambris
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.